In the last trading session, 0.82 million shares of the Allarity Therapeutics Inc (NASDAQ:ALLR) were traded, and its beta was -0.13. Most recently the company’s share price was $1.06, and it changed around -$0.05 or -4.50% from the last close, which brings the market valuation of the company to $18.10M. ALLR currently trades at a discount to its 52-week high of $36.90, offering almost -3381.13% off that amount. The share price’s 52-week low was $0.61, which indicates that the current value has risen by an impressive 42.45% since then.
Allarity Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ALLR as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Instantly ALLR has showed a red trend with a performance of -4.50% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.2300 on recent trading dayincreased the stock’s daily price by 13.82%. The company’s shares are currently down -9.40% year-to-date, but still down -0.93% over the last five days. On the other hand, Allarity Therapeutics Inc (NASDAQ:ALLR) is 29.03% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 84.72%.
ALLR Dividends
Allarity Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 7.11 shares worth $7540.0, making up 0.04% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 3.3 shares worth around $3493.0, which represents about 0.02% of the total shares outstanding.
